Financials

v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 4,960,000 $ 6,811,000
Restricted cash 94,000 94,000
Deferred offering costs 507,000 634,000
Prepaid expenses and other current assets 227,000 567,000
TOTAL ASSETS 5,788,000 8,106,000
Current liabilities    
Accounts payable 1,016,000 748,000
Accrued expenses 1,203,000 1,560,000
Warrant liability 11,000
Total Current Liabilities 2,219,000 2,319,000
Stockholders’ Equity    
Preferred stock value 1,000 1,000
Common stock, par value $0.001, 250,000,000 shares authorized, 44,668,969 and 25,534,173 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 45,000 26,000
Additional paid in capital 734,952,000 729,661,000
Accumulated deficit (731,429,000) (723,901,000)
Total Stockholders’ Equity 3,569,000 5,787,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 5,788,000 8,106,000
Series L Preferred Stock [Member]    
Stockholders’ Equity    
Preferred stock value

Source

v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development 1,055,000 363,000 1,468,000 1,462,000
Selling, general and administrative 3,457,000 1,150,000 5,892,000 1,983,000
Loss from Operations (4,512,000) (1,513,000) (7,360,000) (3,445,000)
Other Income (Expense)        
Interest income 58,000 38,000 125,000 70,000
Interest expense (64,000) (127,000)
Loss on initial recognition of Greenshoe Rights liability   (28,736,000)   (28,736,000)
Change in fair value of warrant liability (114,000) 11,000 12,000
Gain on settlement of vendor payable 998,000
Other income 156,000 156,000
Total Other Income (Expense), net (6,000) (28,656,000) 9,000 (27,500,000)
Net Loss (4,518,000) (30,169,000) (7,351,000) (30,945,000)
Dividend on preferred stock (74,000) (85,000) (177,000) (85,000)
Deemed dividend (433,000)
Net Loss attributable to common stockholders’ $ (4,592,000) $ (30,254,000) $ (7,961,000) $ (31,030,000)
Net Loss Per Share - Basic $ (0.12) $ (10.92) $ (0.23) $ (12.12)
Net Loss Per Share - Diluted $ (0.12) $ (10.92) $ (0.23) $ (12.12)
Weighted average common shares outstanding - basic 38,820,657 2,771,765 34,575,429 2,559,604
Weighted average common shares outstanding - diluted 38,820,657 2,771,765 34,575,429 2,559,604

Source

v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (30,169,000) $ (7,351,000) $ (30,945,000)
Adjustments to reconcile net loss to net cash used in operating activities:      
Fair value of vested stock options   92,000 7,000
Issuance of warrants for VRT waiver     44,000
Loss on initial recognition of Greenshoe Rights liability 28,736,000   28,736,000
Change in fair value of warrant liability 114,000 (11,000) (12,000)
Gain on settlement of debt (998,000)
Gain on extinguishment of debt   (200,000)
Changes in operating assets and liabilities:      
(Increase) Decrease in prepaid expenses   631,000 (225,000)
Increase (Decrease) in accounts payable and accrued expenses   (89,000) (1,623,000)
Net Cash Used in Operating Activities   (6,728,000) (5,216,000)
CASH FLOWS FROM INVESTING ACTIVITIES  
CASH FLOWS FROM FINANCING ACTIVITIES      
Exercise of warrants for cash, net   577,000 1,052,000
Proceeds from issuance of Series L convertible preferred stock and warrants, net   4,300,000 5,441,000
Net Cash Provided by Financing Activities   4,877,000 6,493,000
Net Increase (Decrease) in Cash and Cash Equivalents and Restricted Cash   (1,851,000) 1,277,000
Cash and Cash Equivalents and Restricted Cash at Beginning of Period   6,905,000 4,044,000
Cash and Cash Equivalents and Restricted Cash at End of Period $ 5,321,000 5,054,000 5,321,000
Cash paid during the period for:      
Interest  
Income taxes  
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES      
Fair value of vested warrants issued in Series L conv. preferred stock transaction   3,389,000
Fair value of prefunded warrants issued for ELOC fee   672,000
Fair value of common stock and warrants issued for services   164,000 718,000
Fair value of prefunded warrants and common stock to settle vendor payable   847,000
Conversion of Series L convertible preferred stock into common stock   96,000
Dividend on Series L convertible preferred stock   $ 177,000 $ 85,000

Source